Dare Bioscience (DARE) Misses Q3 EPS by 55c
Tweet
Share
E-mailGet Alerts DARE Hot Sheet
Join SI Premium – FREE
Dare Bioscience (NASDAQ: DARE) reported Q3 EPS of ($0.55). Revenue for the quarter came in at $41.69 million.
For earnings history and earnings-related data on Dare Bioscience (DARE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. and Denmark close in on a Greenland deal - Reuters
- Leidos wins $85m Air Force contract for aerospace design
- Empire Petroleum (EP) files $150M mixed shelf
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
